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Junin virus (JUNV), a highly pathogenic New World arenavirus, is the causative agent of
Argentine hemorrhagic fever (AHF). The live-attenuated Candid #1 (Can) strain currently
serves as a vaccine for at-risk populations. We have previously shown that the Can
glycoprotein (GPC) gene is the primary gene responsible for attenuation in a guinea
pig model of AHF. However, the mechanisms through which the GPC contributes to
the attenuation of the Can strain remain unknown. A more complete understanding
of the mechanisms underlying the attenuation and immunogenicity of the Can strain
will potentially allow for the rational design of additional safe and novel vaccines.
Here, we provide a detailed comparison of both RNA and protein expression profiles
between both inter- and intra-segment chimeric JUNV recombinant clones expressing
combinations of genes from the Can strain and the pathogenic Romero (Rom) strain.
The recombinant viruses that express Can GPC, which were shown to be attenuated in
guinea pigs, displayed different RNA levels and GPC processing patterns as determined
by Northern and Western blot analyses, respectively. Analysis of recombinant viruses
containing amino acid substitutions selected at different mouse brain passages during
the generation of Can revealed that altered Can GPC processing was primarily due
to the T168A substitution within G1, which eliminates an N-linked glycosylation motif.
Incorporation of the T168A substitution in the RomGPC resulted in a Can-like processing
pattern of Rom GPC. In addition, JUNV GPCs containing T168A substitution were
retained within the endoplasmic reticulum (ER) and displayed significantly lower cell
surface expression than wild-type Rom GPC. Interestingly, the reversion A168T in Can
GPC significantly increased GPC expression at the cell surface. Our results demonstrate
that recombinant JUNV (rJUNV) expressing Can GPC display markedly different protein
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expression and elevated genomic RNA expression when compared to viruses expressing
Rom GPC. Additionally, our findings indicate that the N-linked glycosylation motif at
amino acid positions 166–168 is important for trafficking of JUNV GPC to the cell surface,
and the elimination of this motif interferes with the GPC release from the ER.
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INTRODUCTION
The New World arenavirus Junin (JUNV) causes Argentine
hemorrhagic fever (AHF) in humans, a severe potentially lethal
disease endemic to the central regions of Argentina. The virus
genome consists of two single-stranded, negative sense RNA
segments, small (S) and large (L). Both genome segments utilize
an ambisense coding strategy to encode two viral proteins that are
expressed in opposite orientation (Figure 1). The L RNA segment
(∼7 kb) encodes the viral RNA-dependent RNA polymerase
(LP) that replicates and transcribes viral RNA genome and a
small zinc-binding RING finger protein (Z) that is the arenavirus
counterpart of the matrix protein found in many negative strand
RNA viruses. Z has multiple functions in the viral replication
cycle including formation and budding of virions from the
plasma membrane, negative regulation of the activity of the viral
replication complex, and modulation of the host cell response to
infection (Fehling et al., 2012). The S RNA segment (∼3.4 kb)
encodes the glycoprotein precursor (GPC) and the nucleoprotein
(NP). GPC is co- and post-translationally processed by cellular
proteases to yield glycoproteins G1 and G2, and the stable signal
peptide (SSP) that form G1/G2/SSP glycoprotein complexes
present at the surface of mature virions and responsible for
virus receptor recognition and cell entry via receptor mediated
endocytosis (Burri et al., 2012). NP is the most abundantly
present viral protein in both infected cells and virions. NP serves
as an essential co-factor for LP transcription of RNA, and also
blocks the detection of viral RNA by the cellular anti-viral defense
mechanisms (Buchmeier et al., 2013).
The G2-mediated fusion between viral and cellular
membranes in the acid environment of the endosome releases
the viral ribonucleoprotein (vRNP) into the cell cytoplasm,
which is ensued by the onset of viral RNA synthesis. Replication
and expression of arenavirus genome is strictly regulated
during infection. After the genetic material is delivered into the
cytoplasm, the viral polymerase initiates synthesis of genomic
and anti-genomic segment RNA species, as well as mRNA of viral
genes. Studies of the prototypic arenavirus LCMV-infected cells
demonstrated that the maximal level of viral RNA synthesis that
preceded peak virus titers was followed by a marked decrease
in the rate of RNA production (Cornu and de la Torre, 2001).
Therefore, two phases of arenavirus replication cycle have been
proposed: the active genome replication and expression phase
and the virion assembly and budding phase. Z is not required for
RNA synthesis mediated by vRNP but Z was shown to exhibit
a dose-dependent inhibitory effect on the activity of vRNP
(Cornu and de la Torre, 2001). Subsequently, studies with the
FIGURE 1 | Comparison of transcriptional activity between the
polymerase complexes of chimeric JUNV variants. (A) Schematic
representation of rJUNV genomes. Black and gray colors indicate the genetic
material of Rom and Can strains of JUNV, respectively. (B) Levels of
anti-genomic (agRNA) S segment RNA and mRNA of the NP gene in Vero cells
infected with rJUNV. Cells were infected at an MOI of 5 and harvested at 24 h
p.i. Total RNA was isolated and analyzed by Northern blot for viral RNA
species. Equal sample loading and RNA integrity was controlled by EtBr
staining of 18S rRNA. Densitometry was calculated using AlphaEaseTM in
order to determine saturation of each band. Band saturation of the selected
area is represented on a scale from 0 to 255. (C) Comparison between the
activities of Rom and Can LP in minigenome (MG) assays. BHK-21S cells were
transfected with murine pol-I promoter-driven S segment-based minigenome
(MG) constructs expressing firefly luciferase in lieu of either GPC (1GPC/Luc)
or NP (1NP/Luc) gene together with pol-II expression constructs for LP and
NP. The levels of luciferase expression were determined at 48 h after
transfection with Rom (Rom MG/LP+NP) or Can (Can MG/LP+NP)
constructs. RLU, relative light units. (D) Relative viral RNA accumulation
transcribed from either NP (Di) or Z (Dii) gene locus. Vero cells were infected
in the same conditions as in (B) (MOI 5) and harvested at 24 h p.i. Quantitative
RT-PCR using SYBR Green dye was performed in triplicates. Levels of viral
RNA normalized to GAPDH mRNA are expressed as the ratio relative to the
level of viral RNA in cells infected with rRom. Average values and standard
deviations are shown. Romero, rRomero. Candid, rCandid #1. RoL/CaS,
rRomL/CanS. CaL/RoS, rCanL/RomS. Ro/CaNP, rRom/CanNP. Ro/CaGPC,
rRom/CanGPC. Ro/CaLP, rRom/CanLP. Ro/CaZ, rRom/CanZ.
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New World arenavirus Machupo (MACV) demonstrate that Z
forms a direct heterodimeric complex with the homologous LP
and lock the LP in a promoter-bound form, thus preventing
LP from copying the template genome RNA. Interestingly, the
ability of Z to inhibit LP activity from heterologous arenaviruses
was found to correlate with the degree of genetic distance
between the viruses. Thus, the Z of a distantly related Old World
arenavirus LCMV neither interacted nor inhibited the functional
activity of MACV LP (Kranzusch and Whelan, 2011). This
Z-mediated inhibition of vRNP-directed viral RNA synthesis
has been proposed to play an important role in the regulation
of the arenavirus life cycle. Thus, in the early phase of infection,
low concentration of Z allows for active viral RNA synthesis;
however, accumulation over time of high levels of Z in infected
cells leads to the Z-LP complex being locked bound to the viral
promoter, which may facilitate inclusion of the viral polymerase
into arenavirus virions (Kranzusch et al., 2010; Kranzusch and
Whelan, 2011).
A single amino acid change in the transmembrane region
of Candid #1 (Can) G2 has been demonstrated to significantly
attenuate JUNV neurovirulence in mice (Albariño et al., 2011)
and in a guinea pig model that closely reproduces key features
of human AHF (Emonet et al., 2011). This mutation, F427I,
has been shown to destabilize the metastable conformation of
the glycoprotein complex triggering transition to a fusogenic
conformation at neutral pH. This could possibly limit tissue
dissemination of Can (Droniou-Bonzom et al., 2011). However,
the F427I mutation occurred during passages in fetal rhesus
monkey lung FRhL-2 cells (Ambrosio et al., 2011) and cannot
account for the attenuated phenotype associated with the Can
predecessors XJ37 and XJ44 strains of JUNV (Yun et al., 2008).
Previously, the GPC of LCMV has been demonstrated
to induce endoplasmic reticulum (ER) stress and trigger
unfolded protein response (UPR) (Pasqual et al., 2011).
Thus, acute infection with LCMV induced production of
the immunoglobulin heavy-chain-binding protein (BiP), an
ER-resident protein that provides initial folding assistance
to completely unfolded or unstructured nascent polypeptide
chains (Schroder, 2008), and selectively activated the activating
transcription factor 6 (ATF6)-controlled branch of UPR
while the protein kinase RNA-like ER kinase (PERK)- and
the kinase/endonuclease inositol-requiring protein 1 (IRE1)-
regulated pathways were neither activated nor blocked.
Expression of the individual LCMV proteins demonstrated that
only production of the GPC triggered ATF6-mediated UPR,
observed during LCMV-infection. Importantly, rapid down
regulation of GPC expression during transition from acute to
persistent LCMV infection resolved ER stress conditions and
returned UPR signaling to basal levels (Pasqual et al., 2011).
Here, we present evidence that cells infected with rJUNV
expressing the GPC of Can exhibit higher levels of RNA
synthesis and protein production than cells infected with rJUNV
expressing the GPC of the pathogenic Rom strain of JUNV. We
also show that Can GPC exhibits impaired processing and altered
trafficking that promotes induction of the ER stress response and
GPC’s ability to interact with Z. Altered GPC-Z interaction can
influence regulation of replication and expression of the viral
genome, which may contribute to enhanced immunogenicity of
Can.
MATERIALS AND METHODS
Cells and Viruses
African green monkey kidney epithelial Vero, human embryonic
kidney (HEK) 293, and baby hamster kidney (BHK-21) cells
(American Tissue Culture Collection) were maintained in
Dulbecco’s modified Eagle’s medium supplemented with 10%
(Vero and HEK 293) and 5% (BHK-21) fetal calf serum
(HyClone) and an antibiotic-antimycotic solution (Gibco).
Generation and in vitro and in vivo characterization of
the chimeric rJUNV used in the current study has been
described previously (Emonet et al., 2011; Seregin et al.,
2015). Briefly, cDNA of both genome segments of Rom
(GenBank accession numbers AY619640 and AY619641) and
Can (GenBank accession numbers AY746353 and AY746354)
were cloned in antigenomic orientation into a plasmid vector
containing a murine RNA polymerase I promoter (mPol-I)
to generate mPol-I-Sag and mPol-I-Lag plasmids. The open
reading frames (ORF) of the minimal viral trans-acting factors,
NP and LP, required for RNA replication and transcription
by the JUNV polymerase complex, were cloned into an RNA
polymerase II (pol-II) expression plasmid vector to generate pC-
NP and pC-LP plasmids. Chimeric rJUNV were generated by
genetically engineering the ORF of Can genes into the Rom
genome. rJUNV were rescued in BHK21 cells by transfection
with the corresponding mPol-I-Sag and mPol-I-Lag plasmids
together with the pol-II plasmids pC-NP and pC-LP expressing
the NP LP of Rom. Viral stocks were prepared by infecting
Vero cells [multiplicity of infection (MOI)= 0.01] and collecting
virus-containing tissue culture supernatants (TCS) at 4 days
post-infection (p.i.), followed by elimination of cell debris by
centrifugation (10,000 g for 10 min at 4◦C). Work with virulent
strains of JUNV was performed in the UTMB biosafety level
4 (BSL-4) facilities in accordance with institutional health and
safety guidelines.
Northern Blotting
Total RNA from infected cells lysed in TRIzol Reagent
(Invitrogen) was isolated using the Direct-zol RNA MiniPrep
kit (Zymo Research) following the manufacturer’s protocol in
triplicate. The Northern blot analysis was performed using the
NorthernMax-Gly kit (Ambion). Briefly, 1 ug of total RNA was
denatured in glyoxal loading buffer containing EtBr at 50◦C
for 30 min. RNA was separated by electrophoresis in 1% low
electroendosmosis (LE) agarose gel and transferred onto the
BrightStar-Plus positevily charged nylon membrane (Ambion)
by downward passive transfer for 2 h. Before hybridization
with RNA probes, EtBr-stained 18S rRNA was visualized under
long-waive UV light and photographed to assess the quality of
RNA and to ensure equal sample loading. To prepare the RNA
probe for the detection of S gRNA and GPC mRNA species,
a 590 nt PCR fragment was amplified from Romero mPol-I-
Sag spanning positions 743–1333 of the S segment. The probe
was in vitro transcribed using the MAXIscript T7 kit (Ambion)
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from the T7 promoter included in the primer annealing at
position 743 and biotinylated using the BrightStar Psoralen-
Biotin Kit (Ambion) according to the protocols provided by the
manufacturer. The RNA probe targeting the S agRNA and NP
mRNA species was synthesized from a 544 nt PCR fragment
spanning positions 1870–2414 of the S segment of Romero
genome (T7 promoter was included in the primer annealing
at position 2414). Blots were hybridized with biotinylated RNA
probes at 0.1 nM overnight at 68◦C followed by one low-
stringency wash for 10 min at room temperature and two high-
stringency washes for 15 min at 68◦C. Hybridization signals were
detected using the BrightStar BioDetect Nonisotopic Detection
Kit (Ambion). Northern blot band densities were quantified
using AlphaEaseFCTM software.
Quantitative Real-Time PCR
Total RNA from JUNV-infected cells was isolated in triplicate
as described for Northern blot experiments. Viral RNA
quantification was performed in triplicate using the iScript One-
Step RT-PCR Kit with SYBR Green (Bio-Rad) with 100 ng of
total RNA. The following primers were used for detection: NP
direct, GGTCCTTCAATGTCGAGCCA; NP reverse, AATCA
CAGGCAGGTCATGGG; Z direct, AAGTGCTGCTGGTTTGC
TGA; Z reverse, TCCACCGGTACTGTGATTGTG, GAPDH-
Vero direct, AGTCAA CGGATTTGTCGTA; GAPDH-Vero
reverse, GGGTGGAATCATACTGGAAC; GAPDH-guinea pig
direct, TACGACAAGTCCCTCAAGATTG; GAPDH-guinea pig
reverse, TCTGGGTGGCAGTGATGG. Melt curve analysis was
performed to confirm PCR fragment specificity. Sample cycle
thresholds (Ct) were normalized to the Ct values of GAPDH.
Relative amounts of viral RNA in infected cells and tissues
were calculated against rRomero RNA using the equation 2−1Ct,
where 1Ctsample = (Ctsample − CtGAPDH/sample) − (CtrRomero −
CtGAPDH/rRomero) (Pfaﬄ, 2001).
Minigenome Luciferase Assay
Minigenome (MG) luciferase reporter constructs were generated
by replacing both viral genes encoded by the S segment in
Rom and Can mPol-I-Sag with a firefly luciferase (Fluc) and
green fluorescent protein (GFP) genes. Therefore, two reporter
constructs encoding Fluc in lieu of either GPC or NP were
generated for each strain of JUNV. To perform theMG luciferase
assay, BHK-21 cells (seeded at 1 × 105/well in an 12-well plate)
were transfected in triplicate with equimolar amounts of pC-NP,
pC-L, and indicated MG constructs totaling in 2 ug of plasmid
DNA per well. Cells in each well were also co-transfected with an
expression plasmid for Renilla luciferase (100 ng/well) in order to
normalize Fluc luminescence between the samples. Fourty-eight
hours later, Fluc reporter gene expression was assayed using the
Dual-Glo Luciferase Assay System (Promega) according to the
manufacturer’s protocol.
Western Blotting
Infected or transfected cells were harvested in the Laemmli’s SDS
loading buffer (65.8mMTris-HCl, pH 6.8, 2.1% SDS, 26.3% (w/v)
glycerol, 0.01% bromophenol blue, 10% β-mercaptoethanol)
(Bio-Rad). The samples were boiled at 95◦C for 5 min prior
to fractionation by SDS-PAGE in 4–15% Mini-Protean TGX
gels (Bio-Rad). Proteins were transferred to polyvinyl difluoride
(PVDF) membranes using the Trans-Blot Turbo electrotransfer
system (Bio-Rad) according to the manufacturer’s protocol. After
transfer, the membranes were washed ones in distilled water
and blocked in PBS-T (10 mM sodium phosphate, 0.15 M
NaCl, 0.1% Tween-20, pH 7.5) containing 5% non-fat dried
milk for 1 h at room temperature. Then, the membranes
were probed with primary antibodies diluted in blocking
buffer (1:1000) at 4◦C overnight, washed three times for 15
min with PBS-T, and incubated with a secondary antibody
conjugated with the horse radish peroxidase (HRP) (Cell
Signaling) in PBS-T (1:1000) for 1 h at room temperature.
After another wash in PBS-T, the HRP signal was visualized
by enhanced chemoluminescence (ECL) (ECL Western Blotting
System, Amersham). Each Western blot was performed in
triplicate, and a representative blot was presented. The primary
polyclonal antibodies targeting JUNV G2 and Z were raised
in rabbits against synthetic peptides corresponding to amino
acid sequences GKYPNLKKPTVWRR and GASKSNQPDSSRAT
(ProSci), respectively, that are completely conserved between
Romero and Candid #1. The anti-NP monoclonal antibody
NA05-AG12 was obtained from the Biodefense and Emerging
Infections Research Resources Repository (BEI Resources). The
antibodies against BiP and β-actin were purchased from Cell
Signaling Technology, Inc.
Confocal Microscopy
BHK-21S cells were seeded onto NeuVitro glass coverslips
(12 mm, 1.5 thickness, PDL coated) using DMEM containing
5% FBS. After 24 h, cells were transfected with CMV-
driven expression plasmids expressing Romero, XJ13, XJ44,
Candid, RomT168A, or CanA168T GPC. All transfections were
performed using XtremeGENE-9 transfection reagent (Roche)
following the manufacturer’s protocol. The transfected cells were
incubated for 36 h and fixed with 4% paraformaldehyde for
10 min, then permeabilized for 2 min using 0.1% Triton-
X100 in PBS. The cells were stained with CytoPainter Red
ER stain (Abcam) and Hoechst 33342 nuclear stain following
manufacturer’s protocol, then stained with an anti-JUNV GPC
monoclonal mouse antibody (BE08, BEI Resources) for 1 h at
room temperature followed by and AlexaFluor 488 secondary
goat anti-mouse antibody (Life Technologies) for 1 h at room
temperature, each at a 1:500 dilution. The coverslips were
mounted onto slides using MOWIOL mounting solution and
allowed to dry for 24 h. All images were captured using a
Zeiss LSM 510 confocal microscope. Images presented were
representative of multiple frames of view for each sample.
Flow Cytometry
HEK293 cells were seeded into 12-well plates in DMEM
containing 5% FBS. After 24 h, cells were transfected in triplicate
using the same conditions as described for confocal microscopy.
The cells were incubated for 36 h and then placed in a single-cell
suspension, followed by fixation in 4% paraformaldehyde for 10
min at room temperature. Staining was performed using an anti-
JUNV GPC monoclonal mouse antibody (BE08, BEI, Resources)
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for 1 h at room temperature followed by an APC-conjugated goat
anti-mouse secondary antibody (Life Technologies) for 1 h at
room temperature, using a 1:500 dilution for each.
RESULTS
Attenuated Variants of JUNV Exhibit Higher
Levels of RNA Synthesis in Infected Cells
than Virulent Variants
We have previously described generation of recombinant JUNV
(rJUNV) encoding different gene combinations of the pathogenic
Rom and attenuated Can strains of the virus (Seregin et al., 2015)
and identified GPC as the major viral determinant of JUNV
virulence and attenuation in a guinea pig model of AHF (Seregin
et al., 2015). To gain further insights into the molecular basis
by which GPC determines virulence vs. attenuation of JUNV
virulence in vivo, we examined the differential patterns of viral
RNA synthesis and gene expression in cells infected with different
inter- and intrasegment chimeric rJUNVs (Figure 1A). To this
end, Vero cells were infected (MOI = 5) with the inter- and
intrasegment chimeric JUNVs and intracellular levels of viral
RNA were determined by Northern blot analysis. In order to
quantify each of the bands in the Northern blot, AlphaEaseTM
software was utilized to compare band intensity. The values listed
beneath each band (Figure 1B) represent the band saturation
on a scale of 0–255. Intriguingly, we determined that cells
infected with rJUNVs that exhibited a virulent phenotype in
guinea pigs and expressed Rom GPC (rRom, rCanL/RomS, and
rRom/CanNP) accumulated lower amounts of antigenomic S
segment RNA and NP mRNA than cells infected with the viruses
that were attenuated in guinea pigs and expressed the GPC of
Can (rCan, rRomL/CanS, and rRom/CanGPC) (Figures 1B,Di).
While the rCanL/RomS virus agRNA expression was statistically
lower (p < 0.05) than the agRNA expression in viruses that were
attenuated, the difference was not as pronounced as the difference
between the attenuated viruses and either rRom or rRom/CanNP
(p < 0.05). Both rRom and rRom CanNP expressed three-fold
less agRNA than the attenuated viruses. We obtained similar
results for the levels of genomic S RNA and GPC mRNA (data
not shown). Next, the levels of L and S segment RNA synthesis
were evaluated by quantitative PCR using the Z and NP loci,
respectively (qPCR). The data observed in qPCR was similar to
the data obtained for the agRNA in northern blots in terms of
relative RNA expression. The total levels of Z (L segment) and
NP (S segment) RNA were higher in Vero cells infected with the
attenuated variants of rJUNV (Figures 1Di,Dii). This indicated
that the experimental data obtained by qPCR was in agreement
with the data obtained in Northern blot experiments. The slight
differences in relative RNA expression could likely be attributed
to the fact that the qPCR is detecting both genomic RNA and
mRNA, whereas theNorthern blot data distinguishes between the
two.
To investigate possible reasons for the observed discrepancies
in levels of viral RNA synthesis, we examined the activity levels of
Rom and Can vRNPs using establishedminigenome (MG) rescue
systems based on the S segments of Rom and Can (Lee et al.,
2000) where the reporter firefly luciferase marker replaced either
the GPC or NP of JUNV. Surprisingly, we observed similar firefly
luciferase expression with homologous LP/NP combinations of
Rom and Can (Figure 1C). Together, the data indicates that in
cells infected with the different rJUNVs, levels of viral RNA
synthesis were not determined by activity of the core vRNP.
Virulent and Attenuated Variants of rJUNV
Exhibit Different Patterns and Kinetics of
Protein Expression in Infected Cells
Due to the differences in RNA expression between the rJUNVs,
we elected to compare the expression patterns and kinetics
of viral protein production between the rescued rJUNVs
(Figure 2A). Analysis of GP expression in rJUNV-infected Vero
cells revealed two distinct patterns of protein expression for
rJUNVs that exhibited a virulent phenotype in guinea pigs and
expressed Rom GPC and the viruses that were attenuated in
guinea pigs and expressed Can GPC. The lysates of cells infected
with the attenuated viruses (expressing Can GPC) exhibited
differences in uncleaved G1G2 levels, which correlated with
the presence of intermediate bands between G1G2 and G2 in
Western blots. The proportion between the amounts of G2 and
uncleaved G1G2 was notably different, as shown by densitometry
quantification (AlphaEaseTM) of the G1G2 andG2 bands for each
sample. The viruses expressing Can GPC expressed a relatively
equal amount of uncleaved G1G2 and cleaved G2, whereas the
viruses expressing Rom GPC expressed three-fold (CaL/RoS)
of four-fold (Romero, Ro/CaNP) increase in cleaved G2 over
uncleaved G1G2 (Figure 2A). Additionally, there is a presence
of two intermediate bands between the sizes of G1G2 and G2
in cells infected with viruses expressing Can GPC. While these
bands are not present in cells infected with viruses expressing
Rom GPC, it is unclear whether this is due to lower overall
protein expression in these samples or the bands are indicative
of a processing issue with the Can GPC (Figure 2A). Due to the
additional non-specific binding of our antibody to A549 proteins,
these bands are difficult to detect in A549 cells. The relative levels
of G1G2 and G2 for each rJUNV are similar in A549-infected
cells, indicating that the G1G2:G2 ratios observed in Vero cells
are not cell-type specific (Figure 2D).
It is interesting that the total amounts of G2 and G1G2
and the amounts of NP accumulated in cells 48 h after
infection were higher for the rJUNVs that were attenuated in
guinea pigs, compared to the viruses that were virulent for
guinea pigs (Figure 2A). Differences in NP expression levels
appeared early after infection and persisted through 44 h
post-infection (Figure 2B). Likewise, differences in the total
GPC amounts between the virulent and attenuated rJUNV
(Figure 2A) were also observed first at early times p.i., and
persisted throughout the course of infection (Figure 2C).
Interestingly, the presence of additional GPC bands and the
increase in uncleaved G1G2 correlated with lower amounts of Z
(Figure 2A), despite the observed higher RNA levels of theZ gene
locus (Figure 1Dii). Together, these results demonstrate that the
inter- and intrasegment rJUNV expressing Can GPC exhibit a
distinct viral protein expression profile in infected cells that was
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FIGURE 2 | Protein expression profiles and kinetics of chimeric JUNV variants. (A) Differential expression of proteins by Vero cells infected at an MOI of 5.
Cells were lysed in Laemmli’s SDS sample buffer at 48 h p.i. Viral proteins were detected by Western blotting using antibodies raised against conserved regions of G2,
NP, and Z between Rom and Can. Cellular proteins were detected using commercially available antibodies. Densitometry was calculated using AlphaEaseTM in order
to determine saturation of each band. Band saturation of the selected area is represented on a scale from 0 to 255. (B) Kinetics of NP expression. Vero cells infected
at an MOI of 0.1 were collected at the indicated time points and the levels of NP expression were determined by Western blotting. Equal sample loading was
monitored by Comassie blue staining (not shown). (C) GPC expression profile and kinetics of expression between rRom (Romero) and rCan (Candid). Vero cells were
infected at an MOI of 5 and cell lysates were collected at the indicated time points. Western blot was probed with an anti-G2 antibody. (D) Differential expression of
viral GPC and the UPR marker BiP in A549 cells infected with chimeric rJUNV. Cells were infected at an MOI of 5 and harvested at 48 h p.i. The levels of viral and
cellular proteins were determined by Western blotting. Romero, rRomero. Candid, rCandid #1. RoL/CaS, rRomL/CanS. CaL/RoS, rCanL/RomS. Ro/CaNP,
rRom/CanNP. Ro/CaGPC, rRom/CanGPC. Ro/CaLP, Vero, lysate of mock-infected Vero cells. A549, lysate of mock-infected A549 cells.
markedly differed from that of rJUNV expressing the GPC of
the virulent Rom strain, and these viruses express more protein
overall with the exception of Z.
Post-translational Processing of Can GPC
and the ER Stress Response in
GPC-Infected and Transfected Cells
The inter- and intrasegment chimeric JUNVs expressing the GPC
of the attenuated Can exhibited a distinct viral protein expression
profile in infected cells that markedly differed from that of the
viruses expressing the GPC of the virulent Rom (Figure 2A).
Comparison of the GPC expression profiles in Vero and A549
cells showed that the presence of additional bands of intermediate
sizes between G2 and G1G2 for rJUNV expressing the GPC
of Can. The presence of these intermediate bands correlates
with an increase in the presence of uncleaved G1G2 in the cell
lysates, suggesting that these bands could be associated with a
co- or post-translational processing issue. This was observed in
both primate and human cells suggesting the involvement of
co- or post-translational processing mechanisms conserved for
both species. These results allowed us to hypothesize that the
nascent GPC of Can undergoes abnormal processing that results
in decreased production of fully processed G2, ER accumulation
of abnormally processed GPCs in ER, and induction of ER stress.
To examine this hypothesis we assessed expression levels of BiP
in Vero and A549 cells infected with rJUNV expressing the GPC
of either Can or Rom. BiP is an ER chaperone protein that
senses unfolded proteins (UP) in the ER lumen and activates
the cellular UP response (UPR) (Liu et al., 2003). Activation
of BiP expression has previously been utilized to demonstrate
UPR induction in LCMV-infected cells (Pasqual et al., 2011).
Remarkably, both Vero (Figure 2A) and A549 (Figure 2B) cells
exhibited an increase in BiP expression upon infection with
rJUNVs expressing the Can GPC. In contrast, levels of BiP
expression were only slightly elevated in cells infected with
rJUNVs expressing the Rom GPC. Prolonged unresolved ER
stress may result in the induction of apoptosis, which may play
a role in the attenuated phenotype and immunogenicity of Can
(Tabas and Ron, 2011).We therefore examined cells infected with
our chimeric rJUNVs for the presence of markers associated with
ER stress-induced apoptosis signaling. Cells infected with rJUNV
expressing Can GPC showed higher levels of cleaved caspase 3,
and a small increase in both caspase 7 and poly (ADP ribose)
polymerase (PARP) over those infected with rJUNV expressing
Rom GPC. This indicates that expression of Can GPC, but not
Rom GPC, promotes pro-apoptotic UPR signaling in infected
cells (Figure 2A).
To further investigate whether the appearance of additional
GPC species detected by Western blot in cells infected with
rJUNV expressing Can GPC was due to abnormal post-
translational modification of Can GPCs, we treated lysates of
infected Vero cells with the peptide-N-glycosidase F (PNGase F)
to remove N-linked glycans from the protein backbone.
Treatment with PNGase F shifted the protein bands of
intermediate size observed in untreated samples into a single
intermediate band (Figure 3A). The anti-G2 antibody we used
for Western blot exhibited a high degree of non-specific binding
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to PNGase F; however, this band had a higher mobility than the
GPC bands in untreated samples and did not completely mask
the bands between untreated G2 and G1G2 (Figure 3A). These
results indicated that the observed difference in the ratios of
uncleaved G1G2 to cleaved G2 between Rom and Can and the
associated presence of intermediate bands with the accumulation
of G1G2 were likely caused by accumulation of glycosylation
intermediates created in ER processing.
Can was generated by serial in vivo and in vitro passaging
of a virus isolate from a clinical human case of AHF (Parodi
et al., 1958). During this process the virus gradually lost its
virulence for guinea pigs, non-human primates, mice, and
humans (Albariño et al., 2011). To investigate whether the
attenuation of Can correlates with the efficiency of GPC
processing and post-translational modifications, we generated
expression constructs for Rom and Can GPC, as well as the two
Can predecessors XJ13 and XJ44. We also generated constructs
encoding the Rom GPC containing the F427I mutation within
the G2 transmembrane region and the Can GPC containing
the reverse I427F mutation to test whether this amino acid
position that was critical for JUNV neurovirulence in mice
(Albariño et al., 2011) and virulence in guinea pigs (Seregin
et al., 2015) would also play a role in processing and post-
translational glycosylation of GPCs. To this end, we transfected
human embryonic kidney (HEK) 293 cells with the different
GPC constructs and examined the differences in G1G2 to G2
ratios and differences in intermediate band expression, as well
as BiP expression, by Western blot (Figure 3B). Remarkably,
the processing efficiency and glycosylation pattern of GPCs
correlated with the mutations accumulated during the transition
from Rom to Can GPCs (note the appearance of additional bands
and increased mobility of the G1G2 precursor). To quantify this
difference, densitometry was performed using AlphaEaseTM. The
analysis revealed that there is roughly 50% more cleaved G2
than uncleaved G1G2. This shifts to a 2:1 ratio of uncleaved
G1G2 to cleaved G2 in XJ13, a 4:1 ratio of uncleaved G1G2
to cleaved G2 in XJ44, and a 2:1 ratio of uncleaved G1G2 to
cleaved G2 in Can (Figure 3B). As expected, PNGase F treatment
resulted in the disappearance of the intermediate bands into
one single band. In addition, BiP expression levels also slightly
increased in XJ44 and Can-transfected cells even during plasmid
overexpression. Interestingly, the presence of F or I residues
at position 427 neither affected post-translational processing
or glycosylation of either of the GPCs, nor changed the level
of BiP expression. Collectively, these results demonstrated a
correlation between the accumulation of uncleaved G1G2 and
the degree of JUNV attenuation in vivo. The slight increase in
BiP differs from the substantial increase observed in infection.
This could be due to the effects of plasmid overexpression
of the protein, which leads to more rapid expression and
accumulation of the protein than what would be experienced
during infection.
The increase in uncleaved G1G2 begins as early as XJ13 GPC,
and these changes become more pronounced in cells transfected
with XJ44 GPC (Figure 3B). Compared to the highly pathogenic
Rom strain, XJ13 contains three amino acid substitutions, while
only one single additional amino acid substitution that destroys
FIGURE 3 | N-linked glycosylation status of JUNV GPC. (A) Lysates of
Vero cells infected at an MOI of 5 with either rRom (Romero) or rCan (Candid)
were treated with PNGase F to remove N-linked oligosaccharides from protein
backbone. The GPC expression profiles were analyzed by Western blotting
using an anti-G2 antibody. (B) Activation of the UPR in HEK 293 cells
expressing GPC of JUNV strains differing in in vivo attenuation status. Cells
were transfected with equal amounts of expression plasmids for the GPC of
Rom (Romero), Can (Candid), Can predecessor strains XJ13 and XJ44, and
the GPC of Can and Rom bearing I427F (CanI427F) and F427I (RomF427I)
amino acid changes in the G2 subunit, and A168T and T168A amino acid
changes in the G1 subunit (C), respectively. Cell lysates were harvested at 24
h post-transfection and divided into two equal aliquots that were either
mock-treated (top panels) or treated with PNGase F (PNGase F treated).
Expression of viral GPC and the UPR marker BiP was analyzed by Western
blotting. 293, HEK 293 cells transfected with a GFP expressing construct that
shares the same plasmid backbone with the expression constructs for JUNV
GPC. Densitometry was calculated using AlphaEaseTM in order to determine
saturation of each band. Band saturation of the selected area is represented
on a scale from 0 to 255. (C) GPC expression profiles in cells with or without
the T168A substitution. Cells were transfected with equal amounts of each
plasmid and allowed to incubate for 36 h. HEK 293 cell were transfected with
a GFP plasmid containing the same backbone as the GPC expression
plasmids. The cells were lysed and analyzed by Western blotting.
a glycosylation motif at N166 occurred between XJ13 and
XJ44. This single mutation (T168A) in G1 region correlates
with impaired GPC cleavage (Figure 3B). To confirm that the
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T168A substitution is sufficient to cause the observed impaired
processing of XJ44 and CanGPCs, we incorporated this mutation
into the RomGPC expression construct, and the A168T reversion
into the Can GPC expression construct. Western blot analysis
revealed that the T168A mutation in Rom GPC resulted in a
similar G1G2 to G2 ratio to the one observed for XJ44 GPC,
with the lysate containing predominantly uncleaved G1G2. The
A168T reversion increased the processing efficiency of GPC,
yielding an increase in cleaved G2 over what is observed in
Can GPC-transfected cells (Figure 3C). GPCs containing the
mutation T168A, predicted to abrogate N-linked glycosylation at
N166, exhibited faster electrophoretic migration. This strongly
suggests the absence of an N-linked glycan at N166 that is
otherwise present in Rom GPC. It is interesting that the
intermediate bands begin to appear even in the Rom GPC-
transfected samples in a plasmid overexpression systems at later
time points (36 h post-transfection as opposed to 24 h post-
transfection) where the protein is expressed at higher levels
than encountered in infection (Figure 3C). This indicates that
accumulation of uncleaved G1G2 potentially contributes to the
presence of the intermediate bands regardless of the presence of
the glycan at N166. Together, these results demonstrate that the
T168Amutation is a major determinant of the decrease in G1/G2
cleavage in Can GPC. The presence of the intermediate bands
could be indicative of a processing issue and could associate with
an increase in BiP, and both the intermediate bands and BiP
upregulation appear in an overexpression system regardless of
the GPC expressed at later time points.
Glycoproteins of Attenuated Strains of
JUNV Accumulate in the Endoplasmic
Reticulum of Infected Cells
The increase in uncleaved G1G2 in XJ13, XJ44, Can, and Rom-
T168A GPC-expressing cells with respect to cleaved G2 amounts
led us to hypothesize that the uncleaved G1G2 was accumulating
in the ER. The cleavage of G1G2 by SKI-1/S1P occurs in the
late Golgi, suggesting that the protein is not reaching the Golgi
for transport to the cell surface. This ratio of uncleaved G1G2
to cleaved G2 is largest in XJ44 and Rom-T168A GPC, and is
restored partially in Can GPC. XJ44 was passed 19 times in
FRhL cells to generate the seed stocks for Can. During this
time, four additional amino acid substitutions occurred in GPC
(Albarino et al., 2009), which may have resulted in partial rescue
of GPC processing (Figure 3). We therefore examined whether
GPC could efficiently traffic from the ER to the late Golgi where
GPC cleavage occurs, or if the protein was co-localizing with
the ER through the use of confocal microscopy. At 24 h post-
transfection, the majority of Rom GPCs accumulated on the cell
surface, while much lower concentrations remained in the ER.
In contrast, XJ13 GPs were evenly distributed between the ER
and the cell surface. Interestingly, GPs appeared to accumulate
within vesicles in cells expressing XJ13 GPC (Figure 4). While
the identity of these vesicles is unclear, we presume that they are
part of the Golgi apparatus. The XJ44, Can and RomT168A GPCs
predicted to lack the N-linked glycan at N166 co-localized mostly
with the ER, and restoration of the glycosylation motif in Can
GPC (CanA168T) resulted in a larger concentration of GPs at the
cell surface. Notably, patterns of subcellular distribution for the
different GPs correlated with their corresponding GPC cleavage
patterns (Figure 3). These results indicated that mutation T168A,
predicted to eliminate the N-linked glycan at N166, plays an
important role in ER retention of Can GPC, preventing Can GPs
from reaching the cell surface.
Glycoproteins of Virulent Rom, but Not
Attenuated XJ13, XJ44, and Can Are
Efficiently Expressed on Cell Surface
Since the mutation T168A presumably caused the absence of the
N-linked glycan at N166 and the retention of GPs in the ER,
we hypothesized that JUNV GPs containing mutation T168A
would exhibit decreased cell surface expression. To test this
hypothesis, we used flow cytometry to quantify levels of GPs
at the cell surface for each of our GPC constructs (Figure S1).
We split the samples into two separate aliquots, permeabilizing
only one of the aliquots. The non-permeabilized samples allowed
us to quantify GPs present on the cell surface (Figure 5Ai).
Cells transfected with Rom GPC expressed the highest levels of
GPs at the cell surface, and we observed a declined gradient in
GPC cell surface expression from XJ13 to XJ44 and Can GPC
transfected cells. Additionally, we observed a large decreased
in GP surface expression when the G1 N166 glycosylation
motif was removed from Rom GPC. Likewise, we were able to
rescue Can GP surface expression by restoring the T residue
at position 168 (Figure 5Ai). We calculated the percentage of
GPC expressed on the cell surface with respect to the total GPC
from permeabilized cells and compared the samples. Both XJ44
and Can GPC show a decrease in surface expression percentage
compared to Rom GPC (Figure 5Aii). These results indicated
that Rom GPCs efficiently reach the cell surface, while a steady
decline in cell surface expression is observed in XJ13, XJ44,
and Can GPC transfected cells. Expression of GPCs containing
the T168A mutation resulted in only a small fraction of GPCs
reaching the cell surface with respect to Rom GPCs. However,
the decrease in RomT168A surface expression is more directly
linked to a lower total protein expression despite equal plasmid
transfection.
DISCUSSION
The mechanisms responsible for the attenuation of the Can
strain of JUNV, which is currently used as a live-attenuated
vaccine in AHF-endemic regions of Argentina (Ambrosio
et al., 2011), remain to be elucidated. Previous studies have
demonstrated that a single amino acid change (F427I) in the
transmembrane region of the G2 subunit of the envelope
glycoprotein complex significantly attenuates neurovirulence of
JUNV in mice (Albariño et al., 2011). This single substitution
has been proposed to destabilize the metastable conformation
of the glycoprotein complex, favoring its transition to the
fusogenic conformation at neutral pH and possibly limiting
the dissemination of the virus (Droniou-Bonzom et al., 2011).
However, intraperitoneal inoculation of guinea pigs with rRom
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FIGURE 4 | Intracellular localization of JUNV GPC relative to the ER and cell surface. Monolayers of HEK293 cells were transfected with CMV-driven
expression plasmids expressing Romero, XJ13, XJ44, Candid, Romero expressing the T168A substitution (RomT168A), and Candid expressing the A168T reversion
(CanA168T). At 36 h post-transfection, cells were permeabilized and stained with both an ER-selective fluorescent dye (red) and Hoechst 33342 nuclear dye (blue),
and an anti-JUNV GPC primary antibody followed by a conjugated AlexaFluorTM secondary antibody (green). Cells were imaged using a Zeiss LSM 510 confocal
microscope. Both the merged images on a single Z plane (left) and a cross-section of a single representative cell sectioned along along the Z axis (right) are included.
containing the F427I substitution resulted in a self-limiting
acute illness, suggesting that mutation F427I in the G2 can
only partially account for the highly attenuated phenotype of
Can in vivo (Seregin et al., 2015). Moreover, the mutation
F427I was fixed in the JUNV genome during the final stages
of the generation of Can vaccine during passages in FRhL-
2 cells, and after the virus had already achieved attenuation
in guinea pigs and non-human primates (Ambrosio et al.,
2011). This further indicates that other mutations in GPC
are also important for Can attenuation. Consistent with these
findings, only rJUNV expressing the full-length GPC of Can
were completely attenuated and did not induce any detectable
disease symptoms in the guinea pig model of AHF (Seregin et al.,
2015). Interestingly, the Can glycoprotein complex has shown an
increased dependence on the TfR-1 for target cell entry (Droniou-
Bonzom et al., 2011), and the receptor-binding domain has been
mapped to the G1 subunit (Nunberg and York, 2012; Buchmeier
et al., 2013). Therefore, the role of other molecular mechanisms
than those associated with the F427I amino acid change in G2
in attenuation of JUNV would have to be investigated. Among
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 February 2017 | Volume 7 | Article 20
Manning et al. Glycosylation Affects JUNV GPC Trafficking
FIGURE 5 | Cell surface expression of JUNV GPC. Monolayers of HEK293
cells were transfected with CMV-driven expression plasmids previously used in
triplicate (Figure 4). At 24 h post-transfection, the cells were re-suspended
and fixed with 4% paraformaldehyde. The cells were split into two separate
aliquots per sample, and one aliquot was permeabilized with Triton-X100 while
the other was left untreated. The re-suspended cells were stained with an
anti-JUNP GPC primary antibody and subsequently stained with a secondary
antibody conjugated with APC. Suspended cells were subjected to flow
cytometry. (Ai) Bar graph representing the average intensity of
fluorescence-positive cells that were Triton-X100-untreated, expressed in
fluorescence units obtained from individual cells. Fluorescence-positive cells
were gated based on the fluorescence of the mock-transfected HEK293
control group. Average intensity values of the three separate experiments
(bars) and standard error among the triplicates (lines) are both shown. (Aii) Bar
graph representing the percentage of cells expressed on the cell surface. The
aliquots treated with Triton-X100 were stained in the same manner as (Ai) and
the average fluorescence intensities were measured through cell sorting. The
results from (Ai) were divided by the obtained values for the total protein.
Average percentages (bars, expressed as decimal values) and standard error
among triplicates are both shown.
the additional mutations is a single amino acid substitution that
occurred between XJ13 and XJ44 (T168A), which eliminates an
N-linked glycosylationmotif present in G1 (Albarino et al., 2009).
Can and Rom GP exhibited distinctly different G1G2 to G2
ratios that were detected by Western, as well as differences
in the efficiency of GPC processing characterized primarily by
an increase in uncleaved G1G2 and the associated presence of
intermediate bands in the Can GPCs (Figure 2). Treatment with
PNGase F prior to Western blot analysis resulted in detection
only of GPC and G2 species and the collapse of the two
intermediate bands into a single band (Figure 3), supporting
that the intermediate GP bands correspond with an increase
in uncleaved G1G2, and contain various glycosylation profiles.
Interestingly, the presence of the intermediate bands do not
correlate with the presence of specific mutations, but rather the
accumulation of uncleaved G1G2 in the cells. This is supported
by the presence of an intermediate band created by Rom GPC
during plasmid overexpression for 36 h. At this later time point,
even the Rom GPC began to accumulate uncleaved G1G2 within
the transfected cells despite maintaining its cleaved G2 levels.
The faster migration of GPC from both XJ44 and Can (Figure 3)
correlated with the presence of the mutation T168A that is
predicted to remove an N-linked glycosylation motif from N166-
T168. The abnormal glycosylation profile of XJ44 and Can could
result in the accumulation of misfolded proteins in the ER, which
could trigger the ER stress cellular response. Consistent with
this possibility we observed increased expression levels of BiP
in cells infected with viruses expressing Can GPC (Figure 2A).
However, cells transfected with either Rom or Can GPC do
not exhibit as pronounced of a difference in BiP expression.
We believe that this is due to plasmid over-expression in these
cells, where both proteins are expressed at levels much higher
than what is observed during infection, leading to similar BiP
expression. The ER chaperone BiP is the primary detector of ER
stress, and is responsible for the activation of the three main
branches of the UPR through the mediators IRE1, PERK, and
ATF6 (Schroder, 2008). Transient upregulation of BiP was also
found in LCMV-infected cells (Pasqual et al., 2011). Sustained
UPR due to failure to timely resolve accumulation of misfolded
proteins within the ER, will trigger cell apoptosis (Schroder,
2008), a situation that has been described in a number of
virus infections (Dimcheff et al., 2004; Medigeshi et al., 2007;
Barry et al., 2010). Apoptosis has been described to occur
more frequently in Can-infected cells than in Rom-infected
cells (Kolokoltsova et al., 2014), a finding consistent with our
results documenting increased levels of BiP and cleaved caspases
(Figure 2). The correlation between attenuation and UPR-
associated pro-apoptotic signaling indicates that the improper
processing of Can GPC could contribute to a protective immune
response through the upregulation of pro-inflammatory genes
(Zhang and Kaufman, 2008).
The mutation T168A is predicted to destroy an N-linked
glycosylation motif from N166-T168. This mutation arose prior
to XJ44 and correlated with severe impaired GPC processing.
During subsequent passages of XJ44 in FRhL cells to generate
Can, the virus acquired four additional amino acid substitutions
(Ambrosio et al., 2011), leading to a partial rescue of GPC
cleavage and trafficking of GPs to the cell surface (Figure 3C).
We therefore suspected that themutation T168Awas the primary
contributor to the impaired and abnormal processing of Can
GPC. The results of the incorporation of the T168A and A168T
substitutions into plasmids expressing Rom and Can GPC,
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respectively, support this hypothesis (Figure 3C). We observed
that combined expression of all GP species derived from GPC
containing 168A was lower than the one observed for GPC
containing 168T. Based on evidence of the activation of the UPR
in cells expressing GPC deficient of the glycosylation motif, we
suspect that the cause of the decrease in overall GP could be due
to ER-associated degradation (ERAD) triggered by the abnormal
glycosylation of GPC 168A (Vembar and Brodsky, 2008).
Both XJ44 and Can GPC exhibited impaired GPC processing
compared to Rom GPC (Figure 3). Cleavage of GPC into G1
and G2 by SKI-1/S1P does not occur until GPC reaches the
Golgi (Lenz et al., 2001; Beyer et al., 2003). Confocal microscopy
revealed that GPC containing mutation T168A co-localized
mostly with ER markers in transfected cells, supporting the
hypothesis that GPC cleavage was impaired due to ER retention
of GPC. While we cannot rule out the possibility that GPC fails
to be cleaved due to an inherent folding issue that makes the
cleavage motif inaccessible, Western blot analysis indicated that a
fraction of CanGPCwas still cleaved (Figures 2, 3). Furthermore,
the ratios of uncleaved G1G2 to cleaved GPC present in Western
blot analysis (Figure 3B) are in rough correlation with the
fractions of total GPC present on the cell surface for the Rom,
XJ13, XJ44, and Can (Figure 5Aii). Although we describe a
significant difference in protein expression between Rom and
Can GPC at the cell surface, the GPC concentration required
to successfully infect target cells in vitro remains unclear since
the Rom and Can viruses display no significant differences in
infectious particle production in cell culture (Seregin et al., 2015).
The decrease in GPC concentration at the cell surface would
likely affect the concentration of GPC on virus particles, and
while this does not seem to affect the infectivity in cell culture,
there could be a significant effect on infectivity of the virus
in vivo. An LCMV strain with a modified G1G2 cleavage site
(Clone 13FURIN) has previously been shown to be attenuated
despite similar growth in vitro (Popkin et al., 2011). Both the
Rom GPC bearing the single T168A substitution and XJ13
GPC expressed intermediate levels of GP at the cell surface
when compared to Rom and XJ44 GPC, indicating that other
amino acid substitutions present in XJ13 also contributed to the
incorrect trafficking of XJ13 GPs to the cell surface. Interestingly,
XJ13 GP appears to accumulate in small vesicles between the
ER and the cell surface. While the identity of these vesicles has
not been elucidated, we suspect them to be Golgi vesicles. There
are additional N-linked glycosylation trimming steps and quality
controls which take place in the Golgi (Arvan et al., 2002), and
it is possible that one or both of the amino acid substitutions
present in the XJ13 G1 affected the processing and sorting of XJ13
GPs during Golgi quality control.
Reduced expression levels of Can GP complex at the
cell surface (Figure 5) might have contributed to reduced
intracellular levels of Z protein in infected cells that express Can
GPC (Figure 2A). The Z protein interacts with the GP complex
to mediate its incorporation into the budding virion (Capul et al.,
2007; Schlie et al., 2010). It has been shown that budding of
JUNV Z from the cell does not require the presence of the other
viral proteins (Perez et al., 2003). Therefore, it is possible that
the Z protein is budding independently of the Can GP complex.
This hypothesis is supported by the fact that the release of Z
from the cell is inhibited by the co-expression of GPC (Groseth
et al., 2010). This phenomenon of independent Z budding could
also help to explain the differences observed in RNA expression
between the rJUNVs. The increase in RNA in the viruses that
are attenuated also correlates strongly with an absence of Z in
the infected cells. The Z protein is an inhibitor of the LP, and
an absence of the Z protein would lead to a higher polymerase
activity in the infected cells.
Collectively, our findings support the conclusion that Can
GPC induces ER stress through improper post-translational
processing and retention of the viral GP within the ER. The
mechanism of GP retention within the ER and how this
contributes to the attenuation of the live vaccine have yet to be
elucidated.
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Figure S1 | Flow cytometry quantification of surface and total cellular
GPC. HEK293 cells were transfected with CMV-driven GPC expression plasmids
in triplicate. At 24 h post-transfection, the cells were re-suspended and fixed with
4% paraformaldehyde. The cells were split into two separate aliquots per sample,
and one aliquot was permeabilized with Triton-X100 while the other was left
untreated. The re-suspended cells were stained with an anti-JUNP GPC primary
antibody and subsequently stained with a secondary antibody conjugated with
APC. Suspended cells were subjected to flow cytometry. (Ai). Fluorescence
intensities of each cell without treatment with Triton-X100, representing surface
GPC expression. The bar represents the population of positive cells. (Aii).
Fluorescence intensities of each cell with treatment with Triton-X100, representing
total cellular GPC. The bar represents the population of positive cells.
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